These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 20215979

  • 1. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
    Yilmaz M, Adli M, Celen Z, Zincirkeser S, Dirier A.
    Nucl Med Commun; 2010 Jun; 31(6):526-31. PubMed ID: 20215979
    [Abstract] [Full Text] [Related]

  • 2. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
    Kidd EA, Siegel BA, Dehdashti F, Grigsby PW.
    Cancer; 2010 Mar 15; 116(6):1469-75. PubMed ID: 20108309
    [Abstract] [Full Text] [Related]

  • 3. FDG PET-CT in non-small cell lung cancer: relationship between primary tumor FDG uptake and extensional or metastatic potential.
    Zhu SH, Zhang Y, Yu YH, Fu Z, Kong L, Han DL, Fu L, Yu JM, Li J.
    Asian Pac J Cancer Prev; 2013 Mar 15; 14(5):2925-9. PubMed ID: 23803055
    [Abstract] [Full Text] [Related]

  • 4. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.
    Kidd EA, Siegel BA, Dehdashti F, Grigsby PW.
    Cancer; 2007 Oct 15; 110(8):1738-44. PubMed ID: 17786947
    [Abstract] [Full Text] [Related]

  • 5. Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma.
    Shum WY, Hsieh TC, Yeh JJ, Chen JH, Su CC, Liang JA, Kao CH.
    Eur J Radiol; 2012 May 15; 81(5):1024-8. PubMed ID: 21458941
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
    Chung HH, Kang SY, Ha S, Kim JW, Park NH, Song YS, Cheon GJ.
    J Gynecol Oncol; 2016 Mar 15; 27(2):e15. PubMed ID: 26768781
    [Abstract] [Full Text] [Related]

  • 7. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
    Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, Brizel DM.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):548-53. PubMed ID: 21277108
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: potential value in the clinic.
    Li L, Ren S, Zhang Y, Guan Y, Zhao J, Liu J, Wang Q, Chen G, Chen H, Xiang J, Fu X.
    Lung Cancer; 2013 Aug 01; 81(2):213-7. PubMed ID: 23664030
    [Abstract] [Full Text] [Related]

  • 9. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
    Zhao K, Luo XM, Zhou SH, Liu JH, Yan SX, Lu ZJ, Yang SY, Lin LL, Dong MJ.
    Cancer Biother Radiopharm; 2012 Dec 01; 27(10):685-93. PubMed ID: 22834634
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
    Moon SH, Kim HS, Hyun SH, Choi YS, Zo JI, Shim YM, Lee KH, Kim BT, Choi JY.
    J Nucl Med; 2014 May 01; 55(5):743-8. PubMed ID: 24700884
    [Abstract] [Full Text] [Related]

  • 13. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with 18F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer.
    Lin AJ, Wright JD, Dehdashti F, Siegel BA, Markovina S, Schwarz J, Thaker PH, Mutch DG, Powell MA, Grigsby PW.
    Int J Gynecol Cancer; 2019 Nov 01; 29(9):1351-1354. PubMed ID: 31473660
    [Abstract] [Full Text] [Related]

  • 14. Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer.
    Chung HH, Nam BH, Kim JW, Kang KW, Park NH, Song YS, Chung JK, Kang SB.
    Eur J Nucl Med Mol Imaging; 2010 Aug 01; 37(8):1467-73. PubMed ID: 20352210
    [Abstract] [Full Text] [Related]

  • 15. Long-term assessment of clinical parameters and positron emission tomography parameters in predicting recurrence in uterine cervical cancer patients receiving definitive chemoradiotherapy.
    Onal C, Guler OC, Torun N, Reyhan M.
    Nucl Med Commun; 2024 Mar 01; 45(3):203-210. PubMed ID: 38165168
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.
    Kanzaki R, Higashiyama M, Fujiwara A, Tokunaga T, Maeda J, Okami J, Kozuka T, Hosoki T, Hasegawa Y, Takami M, Tomita Y, Kodama K.
    Lung Cancer; 2011 Mar 01; 71(3):333-7. PubMed ID: 20619479
    [Abstract] [Full Text] [Related]

  • 18. Ratio of standardized uptake value on PET helps predict response and outcome after chemotherapy in advanced non-small cell lung cancer.
    Kaira K, Endo M, Asakura K, Tsuya A, Nakamura Y, Naito T, Murakami H, Takahashi T, Yamamoto N.
    Ann Nucl Med; 2010 Dec 01; 24(10):697-705. PubMed ID: 20824397
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.